Document Detail


Efficacy of exercise, losartan, enalapril, atenolol and rilmenidine in subjects with blood pressure hyperreactivity at treadmill stress test and left ventricular hypertrophy.
MedLine Citation:
PMID:  18946484     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
High levels of activity of the renin-angiotensin system (RAS) and sympathetic nervous system (SNS) are related to left ventricular hypertrophy (LVH). A percentage of subjects with hyperactivity to treadmill stress test show LVH to echocardiogram. This paper aims at evaluating neurohumoral influence over these subjects by comparing drugs that block both the RAS and the SNS. In a 1-year open protocol, 195 normotensive subjects, with hyperactivity to treadmill stress test and LVH, were randomly assigned to supervised physical exercise, rilmenidine 1 mg day(-1), atenolol 50 mg day(-1), enalapril 10 mg day(-1) or losartan 50 mg day(-1). Changes in left ventricular mass index (LVMI), measured by means of echocardiogram, were the primary end point. Changes in systolic blood pressure (SBP) at rest and peak effort were also evaluated. Enalapril significantly brought LVMI down in relation to the basal value (28.2%; n=36) similarly to losartan (26.9%; n=42); P>0.05. However, both were more efficient than physical exercise (2.9%; n=39), rilmenidine (5.1%; n=38) and atenolol (7.2%; n=40); P<0.001. There was no significant difference in SBP reduction at rest and peak effort in groups assigned to atenolol, enalapril and losartan; P>0.05. In such groups, reduction was greater than in groups assigned to physical exercise and rimenidine; P<0.001. In conclusion, drugs that block RAS were more efficient in reducing LVH than physical exercise and drugs that block SNS, and such reduction took place regardless of SBP level reduction at rest and peak effort.
Authors:
A C Avanza; A P Mansur; J A F Ramires
Related Documents :
7211694 - Effects of exercise training on left ventricular performance and myocardial perfusion i...
15720454 - Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catechol...
7626354 - Ventricular tachycardia and exercise related syncope in children with structurally norm...
11864924 - Peroxisome proliferator--activated receptor alpha gene regulates left ventricular growt...
16531894 - Changes in adipopnectin, leptin, and fat mass after clenbuterol treatment in horses.
22234914 - Effective exercises for targeting the gluteus medius.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2008-10-23
Journal Detail:
Title:  Journal of human hypertension     Volume:  23     ISSN:  1476-5527     ISO Abbreviation:  J Hum Hypertens     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-23     Completed Date:  2009-08-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  259-66     Citation Subset:  IM    
Affiliation:
Instituto do Coração (InCor) do Hospital das Clínicas da Faculdade de Medicina do Estado de São Paulo, São Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antihypertensive Agents / pharmacology*
Atenolol / pharmacology*
Blood Pressure / drug effects*
Enalapril / pharmacology*
Exercise Test / drug effects*
Exercise Therapy*
Female
Humans
Hypertrophy, Left Ventricular / physiopathology*
Losartan / pharmacology*
Male
Oxazoles / pharmacology*
Renin-Angiotensin System / drug effects*
Sympathetic Nervous System / drug effects*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Oxazoles; 114798-26-4/Losartan; 29122-68-7/Atenolol; 54187-04-1/rilmenidine; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis ...
Next Document:  Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure.